InsidersTradesSigma
Follow the American Well Corp stock price and the full directors' dealings record of the company, a publicly traded company based in United States. Shares trade on the US market, under the authority of SEC (Form 4). Operating in the Healthcare & Pharma sector, American Well Corp has recorded 372 reports. Market capitalisation: €208.4m. The latest transaction was reported on 1 July 2026 (Cession). Among the most active insiders: Gotlib Phyllis. The full history is accessible without an account.
372
Insider Decl.
n/a
Thresholds
€1m
5 ops.
Buy Volume
€27m
287 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate American Well Corp Hold (neutral), based on 5 analysts. Average price target: US$8.90.
52Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 26,989 of 28,833 companies
17.6
score / 100
Value6
Quality29
FCF yld-33%
Earn yld-47%
EV/EBITDA·
ROE-29%
Gross mgn53%
Net mgn-38%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 1 July 2026
Declarations372 total
6,677 sharesClass A Common StockSEC:0001193125-26-292804:0
8,460 sharesClass A Common StockSEC:0001193125-26-292828:0
4,299 sharesClass A Common StockSEC:0001193125-26-292835:0
653 sharesClass A Common StockSEC:0001193125-26-292842:0
14,501 sharesClass A Common StockSEC:0001193125-26-276095:0
14,501 sharesClass A Common StockSEC:0001193125-26-276113:0
14,501 sharesClass A Common StockSEC:0001193125-26-276120:0
14,501 sharesClass A Common StockSEC:0001193125-26-276140:0
14,501 sharesClass A Common StockSEC:0001193125-26-276145:0
14,501 sharesClass A Common StockSEC:0001193125-26-276107:0
9,750 sharesClass A Common StockSEC:0001193125-26-271312:0
112 shares@ US$9.740.0007% mcap0.8% of flowClass A Common StockSEC:0001193125-26-255685:0
3,573 shares@ US$9.740.024% mcap2.0% of flowClass A Common StockSEC:0001193125-26-255692:0
10,761 shares@ US$9.740.071% mcap100.0% of flowClass A Common StockSEC:0001193125-26-255719:0
383 shares@ US$5.301.5% of flowClass A Common StockSEC:0001193125-26-140486:0
5,575 shares@ US$5.30100.0% of flowClass A Common StockSEC:0001193125-26-140493:0
3,706 shares@ US$5.301.1% of flowClass A Common StockSEC:0001193125-26-140539:0
50,413 shares0Class A Common StockSEC:0001193125-26-096838:0
50,413 shares0Class A Common StockSEC:0001193125-26-096806:0
50,413 shares0Class A Common StockSEC:0001193125-26-096801:0
8,066 shares0Class A Common StockSEC:0001193125-26-096783:0
2,472 shares@ US$5.455.4% of flowClass A Common StockSEC:0001193125-26-088984:0
10,796 shares@ US$5.2434.8% of flowClass A Common StockSEC:0001193125-26-088968:0
3,573 shares@ US$5.241.1% of flowClass A Common StockSEC:0001193125-26-088949:0
130 shares@ US$5.240.7% of flowClass A Common StockSEC:0001193125-26-088919:0
25 of 372 declarations
关于 American Well Corp
American Well Corporation 以 Amwell 品牌运营，是一家在美国上市的数字健康公司，在纽约证券交易所 (NYSE) 交易，股票代码为 AMWL。该公司于2006年6月在特拉华州注册成立，总部位于马萨诸塞州波士顿。Amwell 的核心身份是企业远程医疗平台提供商：它构建软件和工作流程基础设施，使健康计划、医院、交付网络、雇主、零售商和公共部门组织能够大规模提供虚拟护理。([sec.gov](https://www.sec.gov/Archives/edgar/data/1393584/000095017025019024/amwl-20241231.htm?utm_source=openai)) 从商业模式角度来看，Amwell 主要通过集成到客户工作流程中的基于 SaaS 的技术支持护理平台实现盈利。其解决方案涵盖广泛的使用场景，包括紧急护理、专科护理、行为健康、慢性病护理、零售健康、学校护理和居家护理。该公司的产品结合了实时视频问诊、护理协调、管理工具和临床数据集成；历史上，它还销售远程医疗亭及相关外围设备。对于投资者而言，重要的区别在于 Amwell 不仅仅是消费者远程医疗应用程序提供商。它被定位为嵌入大型医疗生态系统的企业数字护理基础设施供应商。([sec.gov](https://www.sec.gov/Archives/edgar/data/1393584/000095017025019024/amwl-20241231.htm?utm_source=openai)) 在竞争方面，Amwell 在一个竞争激烈的远程医疗市场中运营，该市场中定价压力、疫情后需求常态化以及深度工作流程集成的需求已成为核心。其竞争优势与企业关系、支付方和提供商分销以及为大型客户运营白标解决方案的能力相关。该公司强调全国范围的合作伙伴关系和多元化的客户群，这支持了其在一个高度分散且技术要求高的市场中的相关性。([sec.gov](https://www.sec.gov/Archives/edgar/data/0001393584/000095017025103029/amwl-ex99_1.htm?utm_source=openai)) 近期发展对于评估该股票至关重要。2026年初，Amwell 通过续签协议扩展了与 Elevance Health 的关系，根据该协议，Amwell 运营一个名为 LiveHealth Online 的白标数字护理交付平台。2026年5月，该公司通过 SEC 文件报告了2026年第一季度业绩。此外，2026年5月6日的一份文件披露，联合创始人 Roy Schoenberg 立即辞去董事会职务，标志着一项值得注意的治理变动。总而言之，这些更新表明商业持续性仍在，但领导层背景也在不断演变，而执行力和盈利能力仍是投资者关注的关键领域。([sec.gov](https://www.sec.gov/Archives/edgar/data/1393584/000119312526007807/amwl-20260105.htm?utm_source=openai))
